A SIMPLE digital directory has been launched to help life science companies connect directly with NHS Scotland when trying to develop joint projects.

Its simplified search process allows firms to find the correct contacts quickly and easily, promoting collaboration, accelerating projects and helping advance new approaches to patient care. It is a database of NHS, clinical, academic and trade organisations, with short descriptions of what they do and contact details.

Companies can also search under four headings – invent, develop, test and sell – to find the correct contacts.

A second-tier search of clinical and technical areas identifies organisations and facilities needed to progress new products.

Dave Tudor, co-chair of the Life Sciences Scotland (LSS) industry leadership group, launched the Scottish Health Research and Innovation Ecosystem directory at its annual conference in Glasgow. The LSS vision is to make Scotland the location of choice for life science businesses, healthcare professionals and investors, as well as increasing the sector’s contribution to Scotland’s economic growth.

Julia Brown, from Scottish Enterprise, said: “Collaboration between industry and NHS

Scotland is key to the life sciences sector and Scotland achieving its potential. Scottish Enterprise is proud to have supported the creation of this new resource to help companies identify and access NHS and health research organisations to develop collaborative working projects and processes, from concept development through to commercialisation.”

Stephen Kelly, NHS Research Scotland (NRS) science manager, said: “The Scottish Health Research and Innovation Ecosystem tool makes it easier for academia, industry and public-sector researchers and innovators to access Scotland’s world class infrastructure and expertise, facilitating the development of innovative diagnostics, therapeutics and devices that will enhance patient care across Scotland and beyond.”

NRS general manager Dr Charles Weller added: “Research and innovation are vital drivers of improved patient care and economic growth, and this tool complements our existing collaborative efforts with the life sciences community to develop new and improved treatments for patients.”